Explore 13 articles covering in-depth insights and practical guidance on synthetic biology for materials & chemicals.
What's working, what isn't, and what's next, with the trade-offs made explicit. Focus on implementation trade-offs, stakeholder incentives, and the hidden bottlenecks.
A practical primer: key concepts, the decision checklist, and the core economics. Focus on KPIs that matter, benchmark ranges, and what 'good' looks like in practice.
A step-by-step rollout plan with milestones, owners, and metrics. Focus on implementation trade-offs, stakeholder incentives, and the hidden bottlenecks.
Comprehensive cost and ROI breakdown for synthetic biology ventures producing bio-based materials and chemicals. Strain development programs range from $2–10M over 18–36 months, while pilot-to-commercial scale-up typically requires $50–200M capex with 5–8 year payback periods depending on molecule value and market size.
The 5–8 KPIs that matter, benchmark ranges, and what the data suggests next. Focus on implementation trade-offs, stakeholder incentives, and the hidden bottlenecks.
Head-to-head comparison of synthetic biology platforms versus petrochemical synthesis for producing bio-based materials and chemicals. Engineered microorganisms now achieve titers above 100 g/L for select molecules, but traditional synthesis still dominates at scale with 70–85% of commodity chemical volume.
Signals to watch, value pools, and how the landscape may shift over the next 12–24 months. Focus on data quality, standards alignment, and how to avoid measurement theater.
A comprehensive state-of-play assessment for Synthetic biology for materials & chemicals, evaluating current successes, persistent challenges, and the most promising near-term developments.
A rigorous look at the most persistent misconceptions about Synthetic biology for materials & chemicals, with evidence-based corrections and practical implications for decision-makers.
Myths vs. realities, backed by recent evidence and practitioner experience. Focus on unit economics, adoption blockers, and what decision-makers should watch next.
Strategic analysis of value creation and capture in Synthetic biology for materials & chemicals, mapping where economic returns concentrate and which players are best positioned to benefit.
A concrete implementation with numbers, lessons learned, and what to copy/avoid. Focus on KPIs that matter, benchmark ranges, and what 'good' looks like in practice.
A practitioner conversation: what surprised them, what failed, and what they'd do differently. Focus on unit economics, adoption blockers, and what decision-makers should watch next.